
Sign up to save your podcasts
Or


The Justice Department's move to reclassify medical marijuana from a Schedule I to a Schedule III drug marks a major federal policy shift with potential ripple effects in Texas. Dylan McKim breaks down what the change means for research and public health, what stays the same, and why some experts warn the move opens the door to profit‑driven expansion without enough safeguards.
By KXAN News5
66 ratings
The Justice Department's move to reclassify medical marijuana from a Schedule I to a Schedule III drug marks a major federal policy shift with potential ripple effects in Texas. Dylan McKim breaks down what the change means for research and public health, what stays the same, and why some experts warn the move opens the door to profit‑driven expansion without enough safeguards.

10,972 Listeners

376 Listeners

56,944 Listeners

5,217 Listeners

172 Listeners

6,462 Listeners

58,365 Listeners

40,434 Listeners

26,679 Listeners

3,472 Listeners

20,222 Listeners